PHASE II CLINICAL TRIAL OF CAPECITABINE IN THE TREATMENT OF ADVANCED, PERSISTENT OR RECURRENT SQUAMOUS CELL CARCINOMA OF THE CERVIX WITH TRANSLATIONAL RESEARCH: A GYNECOLOGIC ONCOLOGY GROUP STUDY

PURPOSE: To evaluate the anti-tumor activity and adverse events of capecitabine in advanced, persistent or recurrent squamous cell carcinoma of the cervix, and to explore biomarkers with the potential to predict capecitabine response and toxicity. EXPERIMENTAL DESIGN: Eligible, consenting patients w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Garcia, Agustin A., Blessing, John A., Darcy, Kathleen M., Lenz, Heinz Josef, Zhang, Wu, Hannigan, Ed, Moore, David H.
Format: Artigo
Idioma:Inglês
Publicat: 2006
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1858667/
https://ncbi.nlm.nih.gov/pubmed/17049588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2006.09.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars